Autologous platelet-rich plasma injection in tennis elbow and plantar fasciitis

    loading  Checking for direct PDF access through Ovid


Background:The introduction of platelet rich plasma (PRP) as a possible adjunct to conservative and operative treatment has motivated significant research into this topic. PRP is a set of autologous platelet products used to accelerate recovery from injury by bringing to the site of injury a set of molecules that will accelerate the functional recovery of the tissue by trying to regenerate it rather than merely repair with scar tissue. In this prospective study, we evaluate the results of PRP in tennis elbow and plantar fasciitis.Methods:During October 2013 to March 2015, 100 patients, 60 with tennis elbow and 40 plantar fasciitis, who visited our center with failed conservative treatment were treated with PRP, and results were evaluated with VAS, DASH and FHSQ scores.Results:Among 60 patients with tennis elbow (24 males and 36 females) post-PRP injection significant differences were observed between VAS and DASH score at baseline and after 4 wk and 8 wk (P<0.001). Among 40 patients with plantar fasciitis (16 males and 24 females) post-PRP injection significant results were observed between VAS and FHSQ scores at baseline and after 4 wk and 8 wk (P<0.001).Conclusions:PRP when given with proper care appears to be helpful in tennis elbow and plantar fasciitis. It is safe and a significant improvement has been observed in VAS and DASH scores for tennis elbow and VAS and FHSQ for plantar fasciitis.

    loading  Loading Related Articles